M&A Deal Summary |
|
|---|---|
| Date | 2020-12-02 |
| Target | LYSTEDA |
| Sector | Life Science |
| Buyer(s) | Amring Pharmaceuticals |
| Sellers(s) | Ferring Pharmaceuticals |
| Deal Type | Divestiture |
SEARCH BY
Amring Pharmaceuticals is a pharmaceutical company that provides value brands and niche generics to the market. The company is part of Sever Life Sciences, BV and is partnered with well-established global biopharmaceutical companies. Amring is uniquely positioned to leverage its partners’ expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-12-18 |
Visant Medical
Menlo Park, California, United States Visant Medical is a clinical-stage medical device company. Visant Medical's Lacrifill cross-linked hyaluronic acid-based canalicular occlusive device. Lacrifill is intended to block tear drainage by occlusion of the canalicular system. Visant Medical is based in Menlo Park, California. |
Buy | - |
Ferring is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. Ferring is headquartered in Saint-Prex, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-04-05 |
Rebiotix
Roseville, Minnesota, United States Rebiotix, Inc. is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionise the treatment of challenging diseases. Rebiotix was founded in 2011 and is based in Roseville, Minnesota. |
Buy | - |
